Kryptos Biotechnologies is at the forefront of innovative biotechnology, focusing on enhancing patient care through advanced diagnostic and analytical tools. Their Infectious Disease Diagnostics feature an integrated sample-to-answer PCR molecular diagnostic system designed for point-of-care testing. This system allows for rapid diagnosis and on-site screening, providing results in just 25 minutes while maintaining the accuracy comparable to traditional laboratory systems. This efficiency is crucial for clinicians, enabling timely treatment decisions, particularly in decentralized clinical settings.

In the realm of Precision Medicine, Kryptos offers a Single-Cell Multinomics System that analyzes multiple analytes within individual cells, delivering comprehensive insights into cancer biology. This PCR-based technology allows oncologists to make informed treatment decisions by examining the heterogeneous nature of cancer cells, thus improving patient outcomes. Central to their technological advancements is the use of photothermal heating, which facilitates ultrafast PCR thermal cycling and precise temperature control, minimizing errors and enhancing the reliability of results. Overall, Kryptos Biotechnologies is committed to developing life-science solutions that combine advanced analytical performance with actionable data to drive impactful healthcare innovations.

United States

Kryptos Biotechnologies is a Life Science startup based in the San Francisco Bay Area. The company uses light to generate heat and control temperature, and provides innovative life science systems that reveal the complexity of biology for clinicians and scientists.

Kryptos Biotechnologies

Company Details